文献速递其他结缔组织病

患者祖源对干燥综合征异质性的影响

Impact of patient ancestry on heterogeneity of Sjögren's disease.
PubMed 文献 · RMD Open · 2023-01-01

这项在法国转诊中心开展的回顾性病例对照研究将74例非洲裔原发性干燥综合征患者与148例白种人患者按随访时长匹配,发现非洲裔患者诊断年龄更轻、γ球蛋白更高、抗SSA和抗RNP抗体阳性率更高,随访期间系统并发症更多、累积ESSDAI评分更高;多因素分析中撒哈拉以南非洲裔、类风湿因子和抗RNP阳性与疾病活动相关。

要点

  • 非洲裔患者诊断年龄中位数43岁,白种人56岁(p<0.001)。
  • 非洲裔患者抗SSA阳性率88% vs 72%,抗RNP 11% vs 2.7%。
  • 非洲裔患者累积ESSDAI中位数7.5 vs 4.0(p=0.002)。

核心结论

  • 非洲裔原发性干燥综合征患者疾病活动度更高,以B细胞活化增强为特征。
  • 作者认为需要开展研究探讨这些差异背后的生物学驱动因素。

研究设计与样本

  • 在法国一家国家级和欧洲转诊中心开展的回顾性病例对照研究。
  • 所有非洲裔原发性干燥综合征患者与两名随访时长相似的白种人患者匹配。
  • 共纳入74例非洲裔患者,匹配148例白种人患者。

主要发现

  • 诊断时中位年龄非洲裔43岁(IQR 33-51)vs 白种人56岁(IQR 44.8-59.2),p<0.001。
  • 中位γ球蛋白水平非洲裔18.5 g/L(IQR 15-22.8)vs 白种人13.4 g/L(IQR 9.9-16.9),p<0.001。
  • 抗SSA抗体阳性率非洲裔88% vs 白种人72%(p=0.007);抗RNP抗体阳性率非洲裔11% vs 白种人2.7%(p=0.023)。
  • 随访中位6年(IQR 2-11)期间,非洲裔患者更常出现关节炎、肌炎、间质性肺病、淋巴结病、中枢神经系统受累等系统并发症。
  • 中位累积ESSDAI评分非洲裔7.5(IQR 3.2-16.0)vs 白种人4.0(IQR 2.0-9.0),p=0.002。

关键数值与推荐

  • 多因素分析中与疾病活动相关的因素:撒哈拉以南非洲裔(OR 2.65,95%CI 1.06至6.94)、类风湿因子(OR 2.50,95%CI 1.28至4.96)、抗RNP阳性(OR 11.1,95%CI 1.88至212)。
  • 累积ESSDAI≥5定义为随访期间各clinESSDAI领域最大值的累积。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We aimed to compare disease characteristics between primary Sjögren's syndrome (pSS) patients of African ancestry (AA) and Caucasian ancestry. METHODS: We conducted a retrospective, case-control study in a French national and European referral centre for pSS. All patients with pSS of AA were matched with two Caucasians patients having similar follow-up duration. We explored clinical and biological parameters associated with a cumulative EULAR Sjögren's Syndrome Disease Activity Index (cumESSDAI ≥5) (consisting of individual clinESSDAI domain maximum throughout follow-up). RESULTS: We identified 74 patients of AA matched with 148 Caucasian. Median age at pSS diagnosis was younger in AA patients (43 years (IQR 33-51) vs 56 years (44.8-59.2), p<0.001). AA patients presented higher median titre of gammaglobulins (18.5 g/L (IQR 15-22.8) vs 13.4 g/L (9.9-16.9), p<0.001), more frequently positive for anti-SSA (88% vs 72%, p=0.007) and anti-RNP (11% vs 2.7%, p=0.023) antibodies. During the follow-up (median: 6 years (IQR 2-11)), AA patients presented more systemic complications: arthritis, myositis, interstitial lung disease, lymphadenopathy, central nervous system involvement. Median cumESSDAI score was higher in AA patients (7.5 (IQR 3.2-16.0) vs 4.0 (IQR 2.0-9.0), p=0.002). Interestingly, in multivariate analyses, factors associated with disease activity were sub-Saharan AA (OR 2.65 (95% CI 1.06 to 6.94)), rheumatoid factor (OR 2.50 (95% CI 1.28 to 4.96)) and anti-RNP positivity (OR 11.1 (95% CI 1.88 to 212)). CONCLUSION: Patients of AA display higher disease activity with a hallmark of higher B-cell activation. Studies to investigate biological drivers behind such differences are needed.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Beydon M, Seror R, Le Guern V, et al. Impact of patient ancestry on heterogeneity of Sjögren's disease. RMD Open. 2023. PMID: 36878621. doi:10.1136/rmdopen-2022-002955

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。